explore -WSS

explore

author：hotspot 2025-08-11 16:24:26 - browse：95

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Ripples from Flovent's discontinuation is killing children with asthma

hotspot

WSS

Ozempic cut risk of death in diabetes patients with chronic kidney disease

What a koala virus tells us about the human genome

New research sheds light on how often breast cancer is overdiagnosed

The White House hikes tariffs on plastic syringes made in China

Bird flu makes raw milk dangerous to consume, mouse study finds

Hottest summer in 2,000 years puts focus on extreme heat, health

focus

explore

hotspot

At least 13 dead in Texas as scorching temps continue

Should insurance cover cosmetic surgery?

Activists slam private health insurers over coverage restrictions

WuXi Biologics beefs up its lobbying operation

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Why some fertility treatments produce more boy babies

In age of alternative facts, a scholarly course on calling out crap

STAT series 'Denied by AI' wins major journalism prizes

What does generative AI mean for health care? We asked experts

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

leisure time

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Lawsuit challenges CMS nursing home minimum staffing rule

WuXi Biologics beefs up its lobbying operation

STAT series 'Denied by AI' wins major journalism prizes

Boston hospital trains restaurant workers on naloxone for overdoses

The world needs the new pandemic treaty

hotspot

hotspot

hotspot

hotspot